Tokyo Tape
Sign in
← Meiji Holdings

Quarterly report · Q3

2269.TEDINET S100SSKZ
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥833.0bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥1.06T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥798.1bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥69.7bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥64.7bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥68.3bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥74.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥66.4bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥74.0bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥69.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥44.9bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥69.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥47.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥48.4bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥49.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥1.24Tat 2023-12-31Cons.Assets
Total assets¥1.14Tat 2023-03-31Cons.Assets
Total assets¥1.21Tat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥442.5bnat 2023-12-31Cons.Liabilities
Total liabilities¥384.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥793.5bnat 2023-12-31Cons.Net assets
Net assets / equity¥751.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥748.1bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥92.3bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥63.5bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥88.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥85.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥64.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥85.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥36.7bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥29.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥36.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥41.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥10.6bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥54.7bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥21.3bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥161.132023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥612023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥247.392022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥168.122022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥49.572022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio60.8%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio58.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥579m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥579m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥1.7bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2023-04-01 → 2023-12-31¥679.5bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2023-04-01 → 2023-12-31¥678.9bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥563m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2023-04-01 → 2023-12-31¥48.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-12-31¥154.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-12-31¥154.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥16m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-12-31¥22.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥833.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥833.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥579m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥71.5bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2022-04-01 → 2022-12-31¥649.9bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2022-04-01 → 2022-12-31¥649.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥542m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2022-04-01 → 2022-12-31¥45.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥14m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-12-31¥21.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥798.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥798.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥557m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥66.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 514
ItemContextValueUnit
Contract liabilitiesCurrentQuarterInstant504000000JPY
Return liabilityPrior1YearInstant18052000000JPY
Return liabilityCurrentQuarterInstant21529000000JPY
Provision for bonusesPrior1YearInstant11375000000JPY
Provision for bonusesCurrentQuarterInstant5650000000JPY
Other clPrior1YearInstant62478000000JPY
Other clCurrentQuarterInstant92359000000JPY
Current liabilitiesPrior1YearInstant266258000000JPY
Current liabilitiesCurrentQuarterInstant324714000000JPY
Bonds payablePrior1YearInstant10000000000JPY
Bonds payableCurrentQuarterInstant10000000000JPY
Long term loans payablePrior1YearInstant39496000000JPY
Long term loans payableCurrentQuarterInstant36494000000JPY
Deferred tax liabilitiesPrior1YearInstant5497000000JPY
Deferred tax liabilitiesCurrentQuarterInstant5181000000JPY
Net defined benefit liabilityPrior1YearInstant56255000000JPY
Net defined benefit liabilityCurrentQuarterInstant57361000000JPY
Provision for directors retirement benefitsPrior1YearInstant76000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant77000000JPY
Other nclPrior1YearInstant7322000000JPY
Other nclCurrentQuarterInstant8668000000JPY
Noncurrent liabilitiesPrior1YearInstant118647000000JPY
Noncurrent liabilitiesCurrentQuarterInstant117783000000JPY
LiabilitiesPrior1YearInstant384905000000JPY
LiabilitiesCurrentQuarterInstant442497000000JPY
Capital stockPrior1YearInstant30000000000JPY
Capital stockCurrentQuarterInstant30000000000JPY
Capital surplusPrior1YearInstant80609000000JPY
Capital surplusCurrentQuarterInstant72410000000JPY
Retained earningsPrior1YearInstant602042000000JPY
Retained earningsCurrentQuarterInstant620429000000JPY
Treasury stockPrior1YearInstant-47502000000JPY
Treasury stockCurrentQuarterInstant-38232000000JPY
Shareholders equityPrior1YearInstant665149000000JPY
Shareholders equityCurrentQuarterInstant684606000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant31598000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant36304000000JPY
Deferred gains or losses on hedgesPrior1YearInstant11000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant-22000000JPY
Foreign currency translation adjustmentPrior1YearInstant17870000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant32872000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-2713000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-2420000000JPY
Valuation and translation adjustmentsPrior1YearInstant46767000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant66734000000JPY
Non controlling interestsPrior1YearInstant39394000000JPY
Non controlling interestsCurrentQuarterInstant42142000000JPY
Net assetsPrior1YearInstant751311000000JPY
Net assetsCurrentQuarterInstant793483000000JPY
Liabilities and net assetsPrior1YearInstant1136217000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass